Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side

NCT06968611 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 640

Last updated 2025-09-11

No results posted yet for this study

Summary

The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved quality of patient-centered diabetic care resulting from the use of automated voice message reminders to sensitize people with DM about the potential for sight loss alongside the provision of free reading glasses.

The main questions it aims to answer are:

1. Will the proportion of patients completing their scheduled DR and DM appointments within 3 weeks of the scheduled date be significantly increased in the group receiving the automated voice messages containing both appointment reminders and messaging about the importance of visit and medication compliance in reducing the risk of vision loss, compared with participant messages which only remind them of their appointments?
2. What is the cost-effectiveness, measured as total intervention cost per additional patient complying with the suggested exam?

Conditions

Interventions

OTHER

Education/information of risk

Participant will receive a message underscoring risk of vision loss from poorly controlled DM, and how this risk can be largely eliminated with excellent compliance with mediations and clinical visits.

OTHER

Free eye glasses

Participants will receive a free pair of reading glass at their first appointment

Sponsors & Collaborators

  • District Diabetes Hospital, Dinajpur district of Bangladesh

    collaborator UNKNOWN
  • Gausul Azam BNSB Eye Hospital, Dinajpur district of Bangladesh

    collaborator UNKNOWN
  • Orbis

    lead OTHER

Principal Investigators

  • Munir Ahmed · Orbis Bangladesh

  • Nathan Congdon · Orbis

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-25
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06968611 on ClinicalTrials.gov